V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270020081 | 270010169 | 1.67 | null | Curative (C) | 2014-11-05 | 2015-09-09 | Methotrexate intrathecal | null | N | 270018521 | LOPP |
| 270020082 | 270014768 | 1.73 | null | Curative (C) | 2014-05-06 | 2014-05-19 | CYCLOPHOSPHAMIDE | null | null | 270018829 | DOXORUBICIN |
| 270020083 | 270017167 | null | 68.95 | Palliative (P) | 2019-10-04 | 2019-10-04 | GEMCITABINE + VINORELBINE | N | null | 270019883 | HYDROXYCARBAMIDE |
| 270020084 | 270010517 | 1.79 | 75 | Curative (C) | null | 2019-02-21 | CVP R | N | N | 270022895 | RATHL TRIAL |
| 270020085 | 270010543 | 1.54 | 92 | Curative (C) | 2018-10-26 | 2018-10-26 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | 2 | N | 270023166 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270020086 | 270010569 | null | 92.2 | Curative (C) | null | 2016-09-26 | Alemtuz+Cyclophos+Fludara Allo | Y | N | 270023443 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270020087 | 270010736 | 1.88 | 66.3 | Palliative (P) | 2018-11-14 | 2018-11-20 | ICE | N | N | 270025878 | ECHELON 1 TRIAL |
| 270020088 | 270015032 | 1.68 | 73.45 | Curative (C) | 2018-06-23 | 2018-07-06 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 270006274 | FOXTROT TRIAL |
| 270020089 | 270010821 | 1.7 | null | Curative (C) | 2017-05-26 | 2017-05-27 | CYCLOPHOSPHAMIDE + ETOPOSIDE | N | N | 270013426 | BORTEZOMIB |
| 270020090 | 270010873 | 1.67 | 71.1 | null | 2019-09-10 | 2019-09-23 | R GCVP | N | null | 270021755 | LENALIDOMIDE |
| 270020091 | 270010900 | 1.82 | null | Palliative (P) | null | 2018-03-14 | LENALIDOMIDE | 2 | N | 270023795 | CETUXIMAB + IRINOTECAN |
| 270020092 | 270010920 | 1.7 | null | Palliative (P) | 2019-02-21 | 2019-02-28 | CARBOPLATIN + GEMCITABINE | N | N | 270024838 | CISPLATIN + ETOPOSIDE |
| 270020093 | 270006578 | null | null | Curative (C) | 2017-12-14 | 2017-12-15 | ABVD | null | null | 270000967 | ABVD |
| 270020094 | 270013195 | null | null | Curative (C) | 2014-11-07 | 2015-01-13 | ABVD | 02 | null | 270003495 | ABVD |
| 270020095 | 270006941 | 1.86 | 81.6 | Palliative (P) | 2016-10-18 | 2016-10-29 | FLUOROURACIL + OXALIPLATIN | 02 | null | 270003773 | OXALIPLATIN + MDG |
| 270020096 | 270006965 | 1.7 | null | Curative (C) | 2018-10-13 | 2018-10-20 | Oxaliplatin + Modified de Gramont | null | N | 270003945 | OXALIPLATIN + MDG |
| 270020097 | 270007078 | null | 62.6 | Palliative (P) | 2019-07-03 | 2019-07-04 | Irinotecan + Modified De Gramont | 2 | N | 270005026 | IRINOTECAN + MDG |
| 270020098 | 270007110 | 1.75 | 80.6 | Palliative (P) | 2019-02-03 | 2019-04-17 | Irinotecan + Modified De Gramont | N | null | 270005418 | IRINOTECAN + MDG |
| 270020099 | 270018005 | 1.74 | 81 | null | 2019-09-03 | 2019-09-11 | Irinotecan + Modified De Gramont | 2 | null | 270006848 | IRINOTECAN + MDG |
| 270020100 | 270007318 | 1.8 | null | Adjuvant (A) | 2018-01-28 | 2018-01-30 | Capecitabine + Oxaliplatin 21day | N | N | 270007906 | CAPECITABINE + OXALIPLATIN |
| 270020101 | 270007325 | 1.86 | 78.4 | Palliative (P) | 2015-07-01 | 2015-07-08 | Capecitabine + Oxaliplatin 21day | 2 | N | 270007931 | CAPECITABINE + OXALIPLATIN |
| 270020102 | 270013464 | 1.65 | 90 | Curative (C) | 2020-01-20 | 2020-01-28 | Capecitabine + Oxaliplatin 21day | N | N | 270008766 | CAPECITABINE + OXALIPLATIN |
| 270020103 | 270018050 | 1.73 | 68 | Palliative (P) | 2020-01-05 | 2020-01-19 | Brentuximab | N | N | 270009154 | BRENTUXIMAB |
| 270020104 | 270007494 | 1.83 | 62.8 | Disease modification (D) | 2018-12-17 | 2019-06-26 | Brentuximab | N | N | 270009455 | BRENTUXIMAB |
| 270020105 | 270016394 | 1.8 | 53.5 | Disease modification (D) | 2019-03-06 | 2019-03-06 | Brentuximab Vedotin | 02 | N | 270009573 | BRENTUXIMAB |
| 270020106 | 270007576 | 1.7 | 75 | Curative (C) | 2017-11-16 | 2017-11-23 | Brentuximab | N | N | 270009887 | BRENTUXIMAB |
| 270020107 | 270018081 | null | 83.6 | Curative (C) | 2015-09-14 | 2018-09-08 | Capecitabine | N | N | 270010050 | CAPECITABINE |
| 270020108 | 270007699 | 1.6 | 87 | Curative (C) | 2016-02-13 | 2016-03-19 | Capecitabine | N | N | 270010476 | CAPECITABINE |
| 270020109 | 270007777 | 1.6 | 57.2 | Palliative (P) | 2018-04-28 | 2018-05-23 | Capecitabine | 02 | N | 270010845 | CAPECITABINE |
| 270020110 | 270018124 | null | null | Curative (C) | 2016-12-10 | 2016-12-10 | CAPECITABINE + OXALIPLATIN | 2 | null | 270010948 | CAPECITABINE + OXALIPLATIN |
| 270020111 | 270007940 | 1.76 | 57.2 | Not known (9) | 2018-11-02 | 2018-11-09 | Capecitabine + Oxaliplatin 14day | N | N | 270011390 | CAPECITABINE + OXALIPLATIN |
| 270020112 | 270008133 | 1.71 | 118 | Adjuvant (A) | 2018-06-24 | 2018-07-03 | Capecitabine + Oxaliplatin 21day | N | N | 270011914 | CAPECITABINE + OXALIPLATIN |
| 270020113 | 270013871 | 1.7 | 99.4 | Curative (C) | 2015-05-30 | 2015-06-02 | Cetuximab 7 day (Cycle 1) | 02 | N | 270011935 | CETUXIMAB |
| 270020114 | 270008162 | 1.72 | 58.55 | Curative (C) | 2015-05-27 | 2015-08-06 | Trial Unspecified | 02 | N | 270011982 | TRIAL |
| 270020115 | 270019084 | 1.71 | 75.3 | Curative (C) | 2015-02-17 | 2015-02-17 | Cetuximab 14 day | N | N | 270012187 | CETUXIMAB |
| 270020116 | 270008319 | 0 | 63.7 | Curative (C) | 2016-10-04 | 2017-01-01 | HD EuroNet-PHL-C1 COPDAC | null | null | 270012463 | TRIAL |
| 270020117 | 270008367 | 1.43 | 68 | Palliative (P) | 2014-09-24 | 2014-11-30 | HD EuroNet-PHL-C1 COPDAC | 02 | null | 270012579 | TRIAL |
| 270020118 | 270008394 | null | 53.2 | Not known (9) | 2018-01-22 | 2018-01-28 | CETUXIMAB | 2 | null | 270012660 | CETUXIMAB |
| 270020119 | 270008438 | 1.7 | 64.4 | Palliative (P) | 2014-02-11 | 2014-03-18 | Cetuximab 14 day | null | N | 270012755 | CETUXIMAB |
| 270020120 | 270016711 | 1.68 | null | null | 2017-01-28 | 2017-02-02 | Escalated BEACOPP | 02 | null | 270013582 | BEACOPP |
| 270020121 | 270018245 | 0 | 61.2 | Adjuvant (A) | null | 2018-01-14 | Trial Unspecified | Y | N | 270013992 | TRIAL |
| 270020122 | 270008724 | 1.79 | null | Disease modification (D) | 2017-01-29 | 2017-02-14 | LEAM | 02 | N | 270014196 | LEAM |
| 270020123 | 270008730 | 1.66 | 50 | Curative (C) | 2016-06-10 | 2016-06-18 | OEPA | 02 | N | 270014220 | OEPA |
| 270020124 | 270008850 | 1.81 | 91.2 | Curative (C) | 2018-06-13 | 2018-07-27 | ESHAP | 02 | null | 270014558 | ESHAP |
| 270020125 | 270008860 | 1.81 | 67.6 | Curative (C) | 2018-04-09 | 2019-07-19 | ESHAP | N | N | 270014564 | ESHAP |
| 270020126 | 270008879 | 1.55 | 62.4 | Disease modification (D) | 2019-03-06 | 2019-03-06 | Rituximab | 2 | Y | 270014596 | RITUXIMAB |
| 270020127 | 270008893 | 1.92 | null | Disease modification (D) | 2014-12-24 | 2015-06-04 | Rituximab | Y | N | 270014625 | RITUXIMAB |
| 270020128 | 270008959 | 1.66 | 92 | Curative (C) | 2017-04-05 | 2017-04-07 | Rituximab | N | null | 270014763 | RITUXIMAB |
| 270020129 | 270009028 | 1.79 | 82 | Curative (C) | 2017-03-31 | 2017-04-02 | OEPA | N | N | 270014886 | OEPA |
| 270020130 | 270019159 | 1.96 | 84.8 | Curative (C) | 2015-12-17 | 2016-02-23 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 270015083 | CISPLATIN + RT |